One hundred consecutive consenting male inpatients in a state of moderately severe , uncomplicated alcohol withdrawal at screening were randomized to receive either lorazepam ( 8 mg/day ) or chlordiazepoxide ( 80 mg/day ) with dosing down-titrated to zero in a fixed-dose schedule across 8 treatment days .
